chr3-101849819-GCTCCGACTC-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM2PM4BP6
The NM_031419.4(NFKBIZ):c.200_208delCCTCCGACT(p.Ser67_Asp69del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.00000272 in 1,472,766 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000023 ( 0 hom. )
Consequence
NFKBIZ
NM_031419.4 disruptive_inframe_deletion
NM_031419.4 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.29
Genes affected
NFKBIZ (HGNC:29805): (NFKB inhibitor zeta) This gene is a member of the ankyrin-repeat family and is induced by lipopolysaccharide (LPS). The C-terminal portion of the encoded product which contains the ankyrin repeats, shares high sequence similarity with the I kappa B family of proteins. The latter are known to play a role in inflammatory responses to LPS by their interaction with NF-B proteins through ankyrin-repeat domains. Studies in mouse indicate that this gene product is one of the nuclear I kappa B proteins and an activator of IL-6 production. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_031419.4.
BP6
Variant 3-101849819-GCTCCGACTC-G is Benign according to our data. Variant chr3-101849819-GCTCCGACTC-G is described in ClinVar as [Likely_benign]. Clinvar id is 2681434.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NFKBIZ | NM_031419.4 | c.200_208delCCTCCGACT | p.Ser67_Asp69del | disruptive_inframe_deletion | 1/12 | ENST00000326172.9 | NP_113607.1 | |
NFKBIZ | NM_001005474.3 | c.-11-2257_-11-2249delCCTCCGACT | intron_variant | NP_001005474.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NFKBIZ | ENST00000326172.9 | c.200_208delCCTCCGACT | p.Ser67_Asp69del | disruptive_inframe_deletion | 1/12 | 1 | NM_031419.4 | ENSP00000325663.5 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151802Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
151802
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000227 AC: 3AN: 1320964Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 651582
GnomAD4 exome
AF:
AC:
3
AN:
1320964
Hom.:
AF XY:
AC XY:
0
AN XY:
651582
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151802Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74134
GnomAD4 genome
AF:
AC:
1
AN:
151802
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74134
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
EBV-positive nodal T- and NK-cell lymphoma Benign:1
Likely benign, no assertion criteria provided | research | Department of Clinical Pathology, School of Medicine, Fujita Health University | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at